Malawi's looming mining boom offers promise and challenge
A new generation of mining projects targeting rare earth and critical minerals could transform Malawi's economy -- but experts warn of the Africa-wide challenges in...
Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant™ System have begun in North America. First unveiled at the American Association for Cancer Research Annual Meeting in April 2026, PrepQuant is now being delivered to customers, marking the platform's progression from development and validation into commercial deployment. The commercial milestone extends Invivoscribe's capabilities in...